Noxopharm Ltd.ASX: NOX

Annual Report to shareholders

Oct 15, 2026 at 7:32 PM EDT · Issued by Noxopharm Ltd. via ASX

Filed with ASX · Oct 15, 2026 at 7:32 PM EDT · 58 pages · English

On 6ix: 6ix.com/news/annual-report-to-shareholders-468

Release

Noxopharm Limited. ABN 50 608 966 123 Level 20, Tower A, The Zenith, 821 Pacific Highway, Chatswood NSW 2067 AUSTRALIA Noxopharm Annual Report Year Ended 30 June 2026 Highlights • Noxopharm Annual Report released today • Substantial progress in clinical trial program • Proprietary...

Noxopharm Ltd. on 6ix

Story so far

Audited Financial StatementsSep 30, 2026

Earlier from Noxopharm

FDA feedback supports SOF-SKN Phase II plansOct 7
Audited Financial StatementsSep 30
SOF-SKN to progress to extension study in CLE patientsSep 13
Investor Presentation September 2026Sep 3
Novel oligonucleotides data presented at Options ConferenceAug 31

Later from Noxopharm

Appendix 4G and Corporate Governance StatementOct 15
2026 AGM Letter of Access, Notice of Meeting and ProxyOct 15
Trading HaltOct 26
Voluntary SuspensionOct 28
Noxopharm Successfully Raises $1.5 Million via PlacementNov 1

All Noxopharm news releases

Follow Noxopharm into a list and get an email when it puts out news.

Follow Noxopharm